Atlas Trials

Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Alendronate (MK-0822-050)

Clinical trial NCT01552122 · WITHDRAWN

Trial details

NCT number
NCT01552122
Sponsor
Merck Sharp & Dohme LLC
Status
WITHDRAWN
Phase
Phase 3
Study type
INTERVENTIONAL
OsteoporosisPostmenopausal Osteoporosis
Start date
2012-05-01
Primary completion
2015-02-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.